33 results
6-K
EX-99.3
CLLS
Cellectis
9 Nov 23
Joint Researchand Collaboration Agreement
4:01pm
, en particulier, que les administrateurs sont en mesure de remplir leur mission.
Le président du conseil ne peut être âgé de plus de 80 ans. Si le … à l’accomplissement de sa mission et de son mandat et peut se faire communiquer tous les documents qu’il estime utiles.
Tout administrateur peut
6-K
EX-99.1
CLLS
Cellectis
3 Aug 23
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
4:35pm
an unprecedented challenging market environment for cell and gene therapy companies, Cellectis remains focused in its mission to develop innovative cancer
6-K
EX-99.1
CLLS
Cellectis
29 Dec 22
Current report (foreign)
4:42pm
is very much in line with Cellectis’ mission to leverage its gene editing technologies to develop potentially life-saving product candidates to address
6-K
EX-99.1
CLLS
Cellectis
3 Nov 22
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2022
4:43pm
to advance the efforts of both our and our partner’s clinical trials. Cellectis remains steadfast in its mission to develop innovative cancer therapy
6-K
EX-99.1
1t0ual
27 Apr 22
Cellectis Receives $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
6:31am
6-K
EX-99.1
jh4ndqk
3 Mar 22
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2021 Financial Results
4:55pm
6-K
EX-99.1
0zi10p2vzyztyrm tk
10 Feb 22
Cellectis Appoints Bing Wang, PhD, MBA
4:35pm
6-K
EX-99.1
krfga9
13 Dec 21
Current report (foreign)
9:02am
6-K
EX-99.1
v51d0jp 31wcm8fc
18 Nov 21
Cytovia and Cellectis Expand Their TALEN® Gene-Edited iNK Partnership to Enable Broader Collaboration in China
4:30pm
6-K
EX-99.1
y973a2w
6 May 21
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
4:34pm
6-K
EX-99.1
8vjan
19 Feb 21
Calyxt Announces Dr. Yves Ribeill Appointed As Executive Chair Replacing
5:17pm
6-K
EX-99.1
8dv08 g3dm5sha4i
16 Feb 21
Cytovia Therapeutics and Cellectis Partner to Develop TALEN® Gene-Edited iPSC-Derived Natural Killer Cells
6:10am
6-K
EX-99.1
0yqxjwl0 2ijm5
16 Dec 20
Cellectis Announces Withdrawal of Follow-On Offering
3:00pm
6-K
EX-99.1
9osu7c65ymaiq0
16 Nov 20
Cellectis Appoints Pharma HR Leader Kyung Nam-Wortman as Executive Vice President, Chief Human Resources Officer
4:30pm
6-K
EX-99.1
il4uprjawy0pk3s7myp
5 Nov 20
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020
4:44pm
6-K
EX-99.1
40d10smj63zh
21 Jul 20
Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing
4:30pm
6-K
EX-99.1
qv787 8qvy
18 May 20
Cellectis Appoints Biopharma Veteran Leopold Bertea as Senior Vice President of Technical Operations - Europe
5:00pm